Most encouraging news from the conference?

Save as Favorite
Sign in to receive recommendations (Learn more)
Question from rebecca: What was the most encouraging news you heard at the San Antonio conference this year?
Answers - Kathy D. Miller, M.D. I think it was the Phase III trial comparing denosumab to Zometa in women with metastatic disease involving the bones. This is an important and common problem for women with metastatic disease. Denosumab was more effective and had fewer side effects, and I think will be a big advance for our patients.

The Ask-the-Expert Online Conference called Updates From the 2009 San Antonio Breast Cancer Symposium featured Kathy Miller, M.D. and Kristin Brill, M.D., F.A.C.S. answering your questions about the latest updates on breast cancer risk, screening techniques, treatment options, and more.

Editor's Note: This conference took place in December 2009.

The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.



Springappeal300x125 nm a
Back to Top